Page last updated: 2024-09-03

n-nor-3-(4'-iodophenyl)tropane-2-carboxylic acid methyl ester and Parkinson Disease

n-nor-3-(4'-iodophenyl)tropane-2-carboxylic acid methyl ester has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choe, YS; Kim, JH; Kim, SE; Lee, WY1

Other Studies

1 other study(ies) available for n-nor-3-(4'-iodophenyl)tropane-2-carboxylic acid methyl ester and Parkinson Disease

ArticleYear
SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.
    Neurological research, 1999, Volume: 21, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Hypothalamus; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon

1999